Phosphorylation of RelA/p65 promotes DNMT-1 recruitment to chromatin and represses transcription of the tumor metastasis suppressor gene BRMS1

Oncogene

Volumn 31, Issue 9, 2012, Pages 1143-1154

  Liu, Y ^a   Mayo, M W ^a   Nagji, A S ^a   Smith, P W ^a   Ramsey, C S ^a   Li, D ^a   Jones, D R ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

DNMT 1; phosphorylation; RelA p65; TNF; transcription

Indexed keywords

DNA METHYLTRANSFERASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; BREAST CANCER METASTASIS SUPPRESSOR 1 GENE; CHROMATIN; CONTROLLED STUDY; EMBRYO; GENE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION;

BINDING SITES; CELL LINE, TUMOR; CHROMATIN; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; PHOSPHORYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; SERINE; TRANSCRIPTION FACTOR RELA; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTORS;

EID: 84857794577     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.308     Document Type: Article

References (54)

1. Baldwin Jr AS. (1996). The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 14: 649-683.
2. Bestor TH. (2000). The DNA methyltransferases of mammals. Hum Mol Genet 9: 2395-2402.
3. Bobrovnikova-Marjon EV, Marjon PL, Barbash O, Vander Jagt DL, Abcouwer SF. (2004). Expression of angiogenic factors vascular endothelial growth factor and interleukin-8/CXCL8 is highly responsive to ambient glutamine availability: role of nuclear factor-kappaB and activating protein-1. Cancer Res 64: 4858-4869.
4. Bours V, Dejardin E, Goujon-Letawe F, Merville MP, Castronovo V. (1994). The NF-kappa B transcription factor and cancer: high expression of NF-kappa B-and I kappa B-related proteins in tumor cell lines. Biochem Pharmacol 47: 145-149.
5. Campbell KJ, Rocha S, Perkins ND. (2004). Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol Cell 13: 853-865.
6. Ceribelli M, Dolfini D, Merico D, Gatta R, Vigano AM, Pavesi G et al. (2008). The histone-like NF-Y is a bifunctional transcription factor. Mol Cell Biol 28: 2047-2058.
7. Chen C, Edelstein LC, Gelinas C. (2000a). The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 20: 2687-2695.
8. Chen FE, Huang DB, Chen YQ, Ghosh G. (1998). Crystal structure of p50/p65 heterodimer of transcription factor NF-kappaB bound to DNA. Nature 391: 410-413.
9. Chen LF, Williams SA, Mu Y, Nakano H, Duerr JM, Buckbinder L et al. (2005). NF-kappaB RelA phosphorylation regulates RelA acetylation. Mol Cell Biol 25: 7966-7975.
10. Chen YQ, Sengchanthalangsy LL, Hackett A, Ghosh G. (2000b). NF-kappaB p65 (RelA) homodimer uses distinct mechanisms to recognize DNA targets. Structure 8: 419-428.
11. Coussens LM, Werb Z. (2002). Inflammation and cancer. Nature 420: 860-867.
12. Denlinger CE, Rundall BK, Jones DR. (2004). Modulation of antiapoptotic cell signaling pathways in non-small cell lung cancer: the role of NF-kappaB. Semin Thorac Cardiovasc Surg 16: 28-39.
13. Di Croce L, Raker VA, Corsaro M, Fazi F, Fanelli M, FarettaMet al. (2002). Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor. Science 295: 1079-1082.
14. Dong J, Jimi E, Zhong H, Hayden MS, Ghosh S. (2008). Repression of gene expression by unphosphorylated NF-kappaB p65 through epigenetic mechanisms. Genes Dev 22: 1159-1173.
15. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. (2004). IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118: 285-296.
16. Greten FR, Karin M. (2004). The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett 206: 193-199.
17. Helbig G, Christopherson II KW, Bhat-Nakshatri P, Kumar S, Kishimoto H, Miller KD et al. (2003). NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278: 21631-21638.
18. Hicks DG, Yoder BJ, Short S, Tarr S, Prescott N, Crowe JP et al. (2006). Loss of breast cancer metastasis suppressor 1 protein expression predicts reduced disease-free survival in subsets of breast cancer patients. Clin Cancer Res 12: 6702-6708.
19. Hoberg JE, Popko AE, Ramsey CS, Mayo MW. (2006). IkappaB kinase alpha-mediated derepression of SMRT potentiates acetylation of RelA/p65 by p300. Mol Cell Biol 26: 457-471.
20. Hodge DR, Xiao W, Peng B, Cherry JC, Munroe DJ, Farrar WL. (2005). Enforced expression of superoxide dismutase 2/manganese superoxide dismutase disrupts autocrine interleukin-6 stimulation in human multiple myeloma cells and enhances dexamethasoneinduced apoptosis. Cancer Res 65: 6255-6263.
21. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. (2002). Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem 277: 3247-3257.
22. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H et al. (2004). NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 114: 569-581.
23. Jones DR, Broad RM, Madrid LV, Baldwin Jr AS, Mayo MW. (2000). Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis. Ann Thorac Surg 70: 930-936; discussion 936-937.
24. Karin M, Greten FR. (2005). NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
25. Kim S, Domon-Dell C, Kang J, Chung DH, Freund JN, Evers BM. (2004). Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem 279: 4285-4291.
26. Kouba DJ, Chung KY, Nishiyama T, Vindevoghel L, Kon A, Klement JF et al. (1999). Nuclear factor-kappa B mediatesTNF-alpha inhibitory effect on alpha 2(I) collagen (COL1A2) gene transcription in human dermal fibroblasts. J Immunol 162: 4226-4234.
27. Liu Y, Denlinger CE, Rundall BK, Smith PW, Jones DR. (2006a). Suberoylanilide hydroxamic acid induces Akt-mediated phosphorylation of p300, which promotes acetylation and transcriptional activation of RelA/p65. J Biol Chem 281: 31359-31368.
28. Liu Y, Smith PW, Jones DR. (2006b). Breast cancer metastasis suppressor 1 functions as a corepressor by enhancing histone deacetylase 1-mediated deacetylation of RelA/p65 and promoting apoptosis. Mol Cell Biol 26: 8683-8696.
29. Mayo MW, Baldwin AS. (2000). The transcription factor NF-kappaB: control of oncogenesis and cancer therapy resistance. Biochim Biophys Acta 1470: M55-M62.
30. Meehan WJ,Welch DR. (2003). Breast cancer metastasis suppressor 1: update. Clin Exp Metastasis 20: 45-50.
31. Mottet D, Pirotte S, Lamour V, Hagedorn M, Javerzat S, Bikfalvi A et al. (2009). HDAC4 represses p21(WAF1/Cip1) expression in human cancer cells through a Sp1-dependent, p53-independent mechanism. Oncogene 28: 243-256.
32. Nagji AS, Liu Y, Stelow EB, Stukenborg GJ, Jones DR. (2010). BRMS1 transcriptional repression correlates with CpG island methylation and advanced pathological stage in non-small cell lung cancer. J Pathol 221: 229-237.
33. Neumann M, Grieshammer T, Chuvpilo S, Kneitz B, Lohoff M, Schimpl A et al. (1995). RelA/p65 is a molecular target for the immunosuppressive action of protein kinase A. EMBO J 14: 1991-2004.
34. Okano M, Bell DW, Haber DA, Li E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99: 247-257.
35. Pikarsky E, Porat RM, Stein I, Abramovitch R, Amit S, Kasem S et al. (2004). NF-kappaB functions as a tumour promoter in inflammation-associated cancer. Nature 431: 461-466.
36. Puto LA, Reed JC. (2008). Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Genes Dev 22: 998-1010.
37. Romano A, Adriaens M, Kuenen S, Delvoux B, Dunselman G, Evelo C et al. (2010). Identification of novel ER-alpha target genes in breast cancer cells: gene-and cell-selective co-regulator recruitment at target promoters determines the response to 17beta-estradiol and tamoxifen. Mol Cell Endocrinol 314: 90-100.
38. Sankpal NV, Willman MW, Fleming TP, Mayfield JD, Gillanders WE. (2009). Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion. Cancer Res 69: 753-757.
39. Schwarze SR, Dowdy SF. (2000). In vivo protein transduction: intracellular delivery of biologically active proteins, compounds and DNA. Trends Pharmacol Sci 21: 45-48.
40. Shaw J, Zhang T, Rzeszutek M, Yurkova N, Baetz D, Davie JR et al. (2006). Transcriptional silencing of the death gene BNIP3 by cooperative action of NF-kappaB and histone deacetylase 1 in ventricular myocytes. Circ Res 99: 1347-1354.
41. Smith PW, Liu Y, Siefert SA, Moskaluk CA, Petroni GR, Jones DR. (2009). Breast cancer metastasis suppressor 1 (BRMS1) suppresses metastasis and correlates with improved patient survival in nonsmall cell lung cancer. Cancer Lett 276: 196-203.
42. Snyder M, Huang XY, Zhang JJ. (2010). Stat3 directly controls the expression of Tbx5, Nkx2.5, and GATA4 and is essential for cardiomyocyte differentiation of P19CL6 cells. J Biol Chem 285: 23639-23646.
43. Suzuki MM, Bird A. (2008). DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9: 465-476.
44. Takada Y, Murakami A, Aggarwal BB. (2005). Zerumbone abolishes NF-kappaB and IkappaBalpha kinase activation leading to suppression of antiapoptotic and metastatic gene expression, upregulation of apoptosis, and downregulation of invasion. Oncogene 24: 6957-6969.
45. Ushijima T, Okochi-Takada E. (2005). Aberrant methylations in cancer cells: where do they come from? Cancer Sci 96: 206-211.
46. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G. (2003). Transcriptional activation of the NF-kappaB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J 22: 1313-1324.
47. Wang CY, Mayo MW, Baldwin Jr AS. (1996). TNF-and cancer therapy-induced apoptosis: potentiation by inhibition of NFkappaB. Science 274: 784-787.
48. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin Jr AS. (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281: 1680-1683.
49. Wehbe H, Henson R, Meng F, Mize-Berge J, Patel T. (2006). Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression. Cancer Res 66: 10517-10524.
50. Xia D, Srinivas H, Ahn YH, Sethi G, Sheng X, Yung WK et al. (2007). Mitogen-activated protein kinase kinase-4 promotes cell survival by decreasing PTEN expression through an NF kappa B-dependent pathway. J Biol Chem 282: 3507-3519.
51. Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. (2005). STAT3-and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA 102: 6948-6953.
52. Zhang Z, Yamashita H, Toyama T, Yamamoto Y, Kawasoe T, Iwase H. (2006). Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin Cancer Res 12: 6410-6414.
53. Zhong H, May MJ, Jimi E, Ghosh S. (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9: 625-636.
54. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S. (1997). The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89: 413-424.